Search

Your search keyword '"Morey L"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Morey L" Remove constraint Author: "Morey L" Database Unpaywall Remove constraint Database: Unpaywall
96 results on '"Morey L"'

Search Results

1. Publisher Correction: Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD

4. Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD

7. Supplementary Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors

8. Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors

9. Supplementary Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors

10. Precipitation of greigite and pyrite induced by Thermococcales: an advantage to live in Fe‐ and S‐rich environments?

12. Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors

13. Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors

15. The Combinatorial Activity of Eftozanermin (ABBV-621), a Novel and Potent TRAIL Receptor Agonist Fusion Protein, in Pre-Clinical Models of Hematologic Malignancies

17. Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor

24. Clearance of systemic hematologic tumors by venetoclax (Abt‐199) and navitoclax

26. Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

27. Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

29. Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity

30. Abstract C249: Detection of tissue and bone marrow clearance of systemically engrafted hematologic tumors by ABT-199 and navitoclax using bioluminescent imaging.

32. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

33. The diagnosis of personality disorders

34. The diagnosis of personality disorders

41. Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity

46. Personality traits as prospective predictors of suicide attempts

48. Improvement in borderline personality disorder in relationship to age

Catalog

Books, media, physical & digital resources